Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acent-SD
- Development stage
- Unknown
- Lead developer
- Intra Labs
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Acent-SD is a combination oral tablet containing the non-steroidal anti-inflammatory drug (NSAID) aceclofenac (100 mg) and the proteolytic enzyme serratiopeptidase (15 mg). Developed by Intra Labs, it is indicated for the relief of pain, inflammation, and swelling associated with various musculoskeletal and joint conditions, such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, muscle strains, sprains, and post-surgical or dental pain. Aceclofenac works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of inflammatory prostaglandins. Serratiopeptidase, an enzyme derived from *Serratia marcescens*, breaks down abnormal proteins at the site of inflammation, helping to reduce swelling and promote tissue repair.
- Brand names
- Acent-SDAcent-SD Tabs
- Other names
- aceclofenac + serratiopeptidase
02
Targets
BK (Bradykinin)Fibrin (Factor Ia)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Acent-SD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acent-SD.